Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
\Cardiometabolic Risk: Reduced blood pressure, triglycerides, and inflammatory markers
Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors
Effective wound filling and infection prevention are crucial, especially in cases of irregularly shaped wounds 60,61
Oxytocin, erectile function and sexual behavior: last discoveries and possible advances
US$ 22.97
US$ 20.76
US$ 22.91
